Bell Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.83M Sell
10,833
-10,062
-48% -$2.58M 1.02% 24
2026
Q2
$5.26M Buy
20,895
+3,707
+22% +$798K 1.4% 13
2026
Q1
$3.74M Buy
+17,188
New +$3.81M 1.1% 32

Other funds holding ABBV

Bell Asset Management's ABBV Position: Q3 2026 in Review

Bell Asset Management reduced its AbbVie (ABBV) stake by 48% in Q3 2026, selling an estimated $2.58M and leaving 10,833 shares worth $2.83M. The position accounts for 1.02% of the portfolio, ranked #24.

Bell Asset Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.26M in Q2 2026. 2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Bell Asset Management held 10,833 shares of AbbVie worth $2.83M as of Q3 2026.
  • Bell Asset Management sold 10,062 AbbVie shares in Q3 2026, an estimated $2.58M.
  • AbbVie made up 1.02% of Bell Asset Management's portfolio in Q3 2026, its #24 holding.
  • Bell Asset Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • Bell Asset Management's AbbVie position peaked at $5.26M in Q2 2026.
  • 2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Bell Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.